Diagnosed Prevalent Cases of Fabry Disease in The 7MM Will Rise at an AGR of 7.71% By 2024 The report,” Fabry Disease - Epidemiology Forecast to 2024 “provides an overview of the risk factors, comorbidities/manifestations, and the global and historical epidemiological trends for Fabry disease in the seven major markets (7MM) (US, France, Germany, Italy, Spain, UK and Japan). It also includes a 10year epidemiological forecast for the diagnosed prevalent cases of Fabry disease in these markets, segmented by age and sex. The Fabry Disease Forecast Report provides an overview of the risk factors, comorbidities, and global trends for Fabry disease in the seven major markets (7MM) (US, France, Germany, Italy, Spain, UK, and Japan). Browse Detailed Toc, Tables, Figures, Charts and Companies Mentioned in Fabry Disease Epidemiology Forecast Report At - http://www.absolutereports.com/epicast-report-fabry-diseaseepidemiology-forecast-to-2024-10076452 Fabry disease is a rare X-linked inherited disorder caused by the deficiency of lysosomal enzyme agalactosidase A (Nagueh, 2003). Fabry disease causes glycolipids such as globotriaosylceramide to accumulate in the vascular endothelium of skin, nervous system, heart and kidneys leading to inflammation and fibrosis resulting in organ dysfunction (Zarate and Hopkins, 2008). Ask for Discount on Fabry Disease - Epidemiology Forecast Report at – http://www.absolutereports.com/enquiry/request-discount/10076452 The Forecasts states that the diagnosed prevalent cases of Fabry disease in the 7MM will increase from 4,538 diagnosed prevalent cases in 2014 to 8,037 diagnosed prevalent cases in 2024, at an AGR of 7.71% during the forecast period. Among the 7MM in 2024, the US will have the highest number of diagnosed prevalent cases of Fabry disease, with 3,540 diagnosed prevalent cases, whereas Spain will have the lowest number, with 523 diagnosed prevalent cases. In the 5EU, Germany will have the highest number of diagnosed prevalent cases of Fabry disease in 2024, with 819 diagnosed prevalent cases, and Spain will have the least number, with 523 diagnosed prevalent cases. Japan will have the highest AGR at 8.16%, while Germany will have the lowest AGR at 6.48%. +1 408 520 9750 www.absolutereports.com Request sample PDF of this report at - http://www.absolutereports.com/enquiry/requestsample/10076452 Reasons to buy: - Develop business strategies by understanding the trends shaping and driving the global Fabry disease market. - Quantify patient populations in the global Fabry disease market to improve product design, pricing, and launch plans. - Organize sales and marketing efforts by identifying the sex and age groups that present the best opportunities for Fabry disease therapeutics in each of the markets covered. About Absolute Report: Absolute Reports is an upscale platform to help key personnel in the business world in strategizing and taking visionary decisions based on facts and figures derived from in depth market research. We are one of the top report resellers in the market, dedicated towards bringing you an ingenious concoction of data parameters. Contact– Mr. Ameya Pingaley Absolute Reports +1-408 520 9750 Email – [email protected] Website: www.absolutereports.com +1 408 520 9750 www.absolutereports.com